We work at the convergence of science, medicine, and engineering to reinvent the process of drug discovery and treatment.
The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.
Our faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research, and computer science to accelerate the invention of the life-saving medicines and precision diagnostics that are needed to optimally treat individual patients.
HiTS brings together two approaches:
The Laboratory of Systems Pharmacology makes it possible to study the changes that promote disease and the ways in which therapeutic drugs function at the molecular level.
The Center for Regulatory Science focuses on evaluating drugs in clinical trials and balancing the benefits and risks of new medicines.
Explore HiTS Research
News, Events, & Updates
Regulatory Science Forum
“Opportunities for Large Language Models in Regulatory Science“
Dr. Tim Miller, Computational Health Informatics Program (CHIP), Boston Children’s Hospital
Tuesday, September 17th, 12:00pm ET
Twitter @Harvard_Lab
Visiting Fellow & President of the @HarvardGSC, Laura König, discusses how she came to serve on the GSC, balancing her research and work on the council, & why she believes student government is a rewarding experience for anyone who chooses to be involved.
I had the honor of being featured by
@HarvardGSAS! This article is highlighting my work as president of the GSC and how building an engaging community is an important part of strong leadership. https://gsas.harvard.edu/preview-link/node/5669/f654a4d3-20c9-421b-8235-6c92bced188b
Fantastic flash talks by Svetlana Djirackor, Tian-Li Wang, Tanjina Kader, Monica Haughan at the @OCMF_Conference in Sioux Falls.
@TanjinaKader @SantagataLab
@shenhui1986 @JBurdetteLab @SanfordResearch
Great panel last night on pre-clinical target validation in #glioblastoma! Peter Sorger, @KeithLigon5, Gabrielle Bergers (@BergersLab) & Deepak Nijhawan discussed cutting-edge approaches to identify and validate promising drug targets. #PrecisionMedicine #DrugDiscovery @sontagfdn
Come join us! Faculty position in tumor immunology at Duke. Joint search between the Dept of Integrative Immunology @ImmunologyDuke and our Dept of Pharmacology and Cancer Biology @Duke_PCB. https://academicjobsonline.org/ajo/jobs/29186